Compugen
CGEN
#8899
Rank
โ‚ฌ0.12 B
Marketcap
1,30ย โ‚ฌ
Share price
-6.21%
Change (1 day)
-16.95%
Change (1 year)

Revenue for Compugen (CGEN)

Revenue in 2025 (TTM): โ‚ฌ6.2 Million

According to Compugen's latest financial reports the company's current revenue (TTM ) is โ‚ฌ5.92 Million. In 2024 the company made a revenue of โ‚ฌ26.77 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ30.26 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Compugen from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ6.2 M-76.84%
2024 โ‚ฌ26.77 M-11.53%
2023 โ‚ฌ30.26 M332.89%
2022 โ‚ฌ6.99 M31.97%
2021 โ‚ฌ5.29 M225.82%
2020 โ‚ฌ1.62 M
2019 N/A-100%
2018 โ‚ฌ15.55 M
2017 N/A-100%
2016 โ‚ฌ0.67 M-92.02%
2015 โ‚ฌ8.48 M-16.55%
2014 โ‚ฌ10.16 M295.68%
2013 โ‚ฌ2.56 M1304.69%
2012 โ‚ฌ0.18 M
2011 N/A-100%
2010 โ‚ฌ0.83 M380.4%
2009 โ‚ฌ0.17 M-27.83%
2008 โ‚ฌ0.24 M
2004 โ‚ฌ2.96 M-57.65%
2003 โ‚ฌ7.01 M-33.96%
2002 โ‚ฌ10.61 M-17.47%
2001 โ‚ฌ12.86 M66.93%
2000 โ‚ฌ7.7 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Seagen
SGEN
โ‚ฌ1.97 B 33,223.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ0 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.40 B 242,924.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Genetic Technologies
GENE
โ‚ฌ14.68 M 147.76%๐Ÿ‡ฆ๐Ÿ‡บ Australia